Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death

References

• Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buque A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P et al. Classification of current anticancer immunotherapies. Oncotarget 2014; 5(24):12472-508; PMID:25537519; http://dx.doi.org/10.18632/oncotarget.2998
   PubMed Web of Science ®Google Scholar
• Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spísek R. Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res 2011; 71(14):4821-33; PMID:21602432; http://dx.doi.org/10.1158/0008-5472.CAN-11-0950
   PubMed Web of Science ®Google Scholar
• Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 2010; 29(4):482-91; PMID:19881547; http://dx.doi.org/10.1038/onc.2009.356
   PubMed Web of Science ®Google Scholar
• Obeid M, Panaretakis T, Joza N, Tufi R, Tesniere A, van Endert P, Zitvogel L, Kroemer G. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ 2007; 14(10):1848-50; PMID:17657249; http://dx.doi.org/10.1038/sj.cdd.4402201
   PubMed Web of Science ®Google Scholar
• Koks C, Garg AD, Ehrhardt M, Riva M, Vandenberk L, Boon L, De Vleeschouwer S, Agostinis P, Graf N, Van Gool SW. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death. Int J Cancer 2014; 136(5):E313-25; PMID:25208916; http://dx.doi.org/10.1002/ijc.29202
   PubMedGoogle Scholar
• Vacchelli E, Eggermont A, Sautes-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: oncolytic viruses for cancer therapy. Oncoimmunology 2013; 2(6):e24612; PMID:23894720; http://dx.doi.org/10.4161/onci.24612
   PubMedGoogle Scholar
• Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJ et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012; 31(5):1062-79; PMID:22252128; http://dx.doi.org/10.1038/emboj.2011.497
   PubMed Web of Science ®Google Scholar
• Garg AD, Vandenberk L, Koks C, Verschuere T, Boon L, Van Gool SW, Agostinis P. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma. Sci Transl Med 2016; 8(328):328ra327; PMID:26936504; http://dx.doi.org/10.1126/scitranslmed.aae0105
   Web of Science ®Google Scholar
• Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 2014; 3(9):e955691; PMID:25941621; http://dx.doi.org/10.4161/21624011.2014.955691
   PubMed Web of Science ®Google Scholar
• Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M et al. Molecular and translational classifications of DAMPs in immunogenic cell death. Front Immunol 2015; 6: 588; PMID:26635802; http://dx.doi.org/10.3389/fimmu.2015.00588
   PubMed Web of Science ®Google Scholar
• Cao C, Han Y, Ren Y, Wang Y. Mitoxantrone-mediated apoptotic B16-F1 cells induce specific anti-tumor immune response. Cell Mol Immunol 2009; 6(6):469-75; PMID:20003823; http://dx.doi.org/10.1038/cmi.2009.59
   PubMed Web of Science ®Google Scholar
• Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath S, Dhodapkar MV. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 2007; 109(11):4839-45; PMID:17299090; http://dx.doi.org/10.1182/blood-2006-10-054221
   PubMed Web of Science ®Google Scholar
• Garg AD, Elsen S, Krysko DV, Vandenabeele P, de Witte P, Agostinis P. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. Oncotarget 2015; 6(29):26841-60; PMID:26314964; http://dx.doi.org/10.18632/oncotarget.4754
   PubMed Web of Science ®Google Scholar
• Martins I, Kepp O, Galluzzi L, Senovilla L, Schlemmer F, Adjemian S, Menger L, Michaud M, Zitvogel L, Kroemer G. Surface-exposed calreticulin in the interaction between dying cells and phagocytes. Ann NY Acad Sci 2010; 1209: 77-82; PMID:20958319; http://dx.doi.org/10.1111/j.1749-6632.2010.05740.x
   PubMed Web of Science ®Google Scholar
• Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009; 28(5):578-90; PMID:19165151; http://dx.doi.org/10.1038/emboj.2009.1
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13(1):54-61; PMID:17187072; http://dx.doi.org/10.1038/nm1523
   PubMed Web of Science ®Google Scholar
• van Vliet AR, Martin S, Garg AD, Agostinis P. The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: from sensor to the plasma membrane and beyond. Semin Cancer Biol 2015; 33: 74-85; PMID:25882379; http://dx.doi.org/10.1016/j.semcancer.2015.03.010
   PubMed Web of Science ®Google Scholar
• Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, Mathieu C, Agostinis P. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 2013; 9(9):1292-307; PMID:23800749; http://dx.doi.org/10.4161/auto.25399
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Kepp O, Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J 2012; 31(5):1055-7; PMID:22252132; http://dx.doi.org/10.1038/emboj.2012.2
   PubMed Web of Science ®Google Scholar
• Fucikova J, Moserova I, Truxova I, Hermanova I, Vancurova I, Partlova S, Fialova A, Sojka L, Cartron PF, Houska M et al. High hydrostatic pressure induces immunogenic cell death in human tumor cells. Int J Cancer 2014; 135(5):1165-77; PMID:24500981; http://dx.doi.org/10.1002/ijc.28766
   PubMed Web of Science ®Google Scholar
• Adkins I, Fucikova J, Garg AD, Agostinis P, Spisek R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology 2014; 3(12):e968434; PMID:25964865; http://dx.doi.org/10.4161/21624011.2014.968434
   PubMed Web of Science ®Google Scholar
• Mishra R, Karande AA. Endoplasmic reticulum stress-mediated activation of p38 MAPK, caspase-2 and caspase-8 leads to abrin-induced apoptosis. PLoS One 2014; 9(3):e92586; PMID:24664279; http://dx.doi.org/10.1371/journal.pone.0092586
   PubMedGoogle Scholar
• Uchibayashi R, Tsuruma K, Inokuchi Y, Shimazawa M, Hara H. Involvement of Bid and caspase-2 in endoplasmic reticulum stress- and oxidative stress-induced retinal ganglion cell death. J Neurosci Res 2011; 89(11):1783-94; PMID:21805492; http://dx.doi.org/10.1002/jnr.22691
   PubMed Web of Science ®Google Scholar
• Upton JP, Austgen K, Nishino M, Coakley KM, Hagen A, Han D, Papa FR, Oakes SA. Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress. Mol Cellular Biol 2008; 28(12):3943-51; PMID:18426910; http://dx.doi.org/10.1128/MCB.00013-08
   PubMed Web of Science ®Google Scholar
• Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123(2):321-34; PMID:16239148; http://dx.doi.org/10.1016/j.cell.2005.08.032
   PubMed Web of Science ®Google Scholar
• Blachere NE, Darnell RB, Albert ML. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 2005; 3(6):e185; PMID:15839733; http://dx.doi.org/10.1371/journal.pbio.0030185
   PubMedGoogle Scholar
• Podrazil M, Horvath R, Becht E, Rozkova D, Bilkova P, Sochorova K, Hromadkova H, Kayserova J, Vavrova K, Lastovicka J et al. Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. Oncotarget 2015; 6(20):18192-205; PMID:26078335; http://dx.doi.org/10.18632/oncotarget.4145
   PubMed Web of Science ®Google Scholar
• Zappasodi R, de Braud F, Di Nicola M. Lymphoma immunotherapy: current status. Front Immunol 2015; 6: 448; PMID:26388871; http://dx.doi.org/10.3389/fimmu.2015.00448
   PubMed Web of Science ®Google Scholar
• Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 2012; 4(143):143ra199; PMID:22814852; http://dx.doi.org/10.1126/scitranslmed.3003807
   Web of Science ®Google Scholar
• Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene 2011; 30(10):1147-58; PMID:21151176; http://dx.doi.org/10.1038/onc.2010.500
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K et al. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma. Cancer Res 2012; 72(10):2609-21; PMID:22461509; http://dx.doi.org/10.1158/0008-5472.CAN-11-3185
   PubMed Web of Science ®Google Scholar
• Prasad V, Chandele A, Jagtap JC, Sudheer Kumar P, Shastry P. ROS-triggered caspase 2 activation and feedback amplification loop in beta-carotene-induced apoptosis. Free Radic Biol Med 2006; 41(3):431-42; PMID:16843824; http://dx.doi.org/10.1016/j.freeradbiomed.2006.03.009
   PubMed Web of Science ®Google Scholar
• Sandow JJ, Dorstyn L, O'Reilly LA, Tailler M, Kumar S, Strasser A, Ekert PG. ER stress does not cause upregulation and activation of caspase-2 to initiate apoptosis. Cell Death Differ 2014; 21(3):475-80; PMID:24292555; http://dx.doi.org/10.1038/cdd.2013.168
   PubMed Web of Science ®Google Scholar
• Krumschnabel G, Sohm B, Bock F, Manzl C, Villunger A. The enigma of caspase-2: the laymen's view. Cell Death Differ 2009; 16(2):195-207; PMID:19023332; http://dx.doi.org/10.1038/cdd.2008.170
   PubMed Web of Science ®Google Scholar
• Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004; 14(3):277-87; PMID:15125832; http://dx.doi.org/10.1016/S1097-2765(04)00237-0
   PubMed Web of Science ®Google Scholar